Further analysis of non-matched primary breast tumors and breast cancer metastases from different organs revealed a significantly downregulated BGN expression in lung and brain metastases, and a tendency towards reduced BGN expression in liver metastases (Figure 2I). Here, BGN is linked to breast carcinoma.